A 42-year-old woman with borderline tuberculoid leprosy on treatment develops painful nodules, fever, and neuritis with worsening of existing lesions. Biopsy shows epithelioid granulomas with minimal neutrophils and upregulation of T-cell activity. Which feature best distinguishes this Type 1 lepra reaction from Type 2 (ENL)?

Explanation

## Type 1 vs Type 2 Lepra Reactions: Immunological Basis ### Core Distinction The fundamental difference between Type 1 (reversal) and Type 2 (ENL) reactions lies in **the patient's immune status and leprosy classification**, not just clinical symptoms. ### Immunological Framework **Type 1 (Reversal) Reaction:** - Occurs in patients with **adequate cell-mediated immunity (CMI)** - Seen in **borderline forms** (BT, BB, BL) where immune response is mounting - Driven by **Type IV hypersensitivity** (delayed-type, T-cell mediated) - Represents immune system gaining strength against *M. leprae* - Histology: epithelioid granulomas, few neutrophils **Type 2 (ENL) Reaction:** - Occurs in patients with **poor cell-mediated immunity** - Seen in **lepromatous forms** (LL, BL) with massive bacillary load - Driven by **Type III hypersensitivity** (immune complex deposition) - Represents antigen excess in setting of weak CMI - Histology: neutrophilic infiltration, immune complexes, vasculitis ### Comparison Table | Parameter | Type 1 (Reversal) | Type 2 (ENL) | |-----------|-------------------|---------------| | **Immune Status** | **Good/adequate CMI** | **Poor CMI** | | **Leprosy Forms** | **Borderline (BT, BB, BL)** | **Lepromatous (LL, BL)** | | **Hypersensitivity** | Type IV (T-cell) | Type III (immune complex) | | **Bacillary Load** | Variable, often decreasing | Very high, persistent | | **Histology** | Epithelioid granulomas | Neutrophilic infiltration | | **Antigen–Antibody Ratio** | Antigen scarcity (good response) | Antigen excess (poor response) | ### Key Point: **Type 1 reactions occur in borderline forms where the immune system is strong enough to mount a delayed hypersensitivity response.** Type 2 occurs in lepromatous forms where the immune system is too weak to clear antigen, leading to immune complex accumulation. ### High-Yield: Remember: **Type 1 = Borderline + Good Immunity; Type 2 = Lepromatous + Poor Immunity.** This single distinction predicts histology, mechanism, timing, and treatment. ### Mnemonic: **"Type 1 is Borderline's Blast; Type 2 is Lepromatous' Last"** — Type 1 occurs when the immune system is gaining strength (borderline forms); Type 2 occurs in the lepromatous end where immunity is weakest. ### Clinical Pearl: A patient with borderline leprosy developing a reaction is mounting a good immune response (Type 1). A patient with lepromatous leprosy developing a reaction is drowning in antigen and antibody (Type 2). The leprosy form at presentation tells you which reaction to expect. [cite:Park 26e Ch 17]